Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Meropenem (500mg) Injection
Therapeutic Category
Antibacterials, Antibiotic, General and OTC medicines
Dosage Form
Injection
Packaging Type
vial
Packaging
500mg
Price
₹758/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Merotyle 500 Injection is a broad-spectrum antibiotic belonging to the carbapenem class. It is highly effective against a wide range of bacterial infections, including both gram-positive and gram-negative bacteria, as well as anaerobes. Meropenem inhibits bacterial cell wall synthesis, leading to cell death and eradication of the infection.
This medication is primarily used in the treatment of severe or complicated infections such as pneumonia, intra-abdominal infections, urinary tract infections, bacterial meningitis, and sepsis. Its potent activity against multidrug-resistant organisms makes it a critical choice for managing life-threatening infections.
Administered intravenously, Meropenem 500 Injection ensures rapid and effective treatment, with reliable distribution to infected tissues. It is often employed in hospital settings for patients who require immediate and potent antibacterial therapy.
May cause nausea, vomiting, diarrhea, rash, or injection site reactions. Rarely, allergic reactions or seizures may occur.
Used for severe bacterial infections such as pneumonia, meningitis, sepsis, and intra-abdominal infections caused by susceptible organisms.
Administer only under medical supervision. Complete the prescribed course to prevent resistance.
Store below 25°C in a dry place, protected from light and moisture.
Composition : Meropenem (1000mg) Injection
Composition : Meropenem (1000mg) + Sulbactam (500mg)
Composition : Meropenem (250mg)
Composition : CEFUROXIME 250 MG + CLAVULANATE 125 MG
Composition : Cefuroxime (250mg)
Composition : Cefuroxime (500mg)
Composition : Cefuroxime (125mg)
Composition : Cefixime (200mg)
Composition : Cefixime (400mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Meropenem 500 mg Injection is a broad-spectrum carbapenem antibiotic used for the treatment of moderate to severe bacterial infections such as pneumonia, sepsis, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, and hospital-acquired infections. It is a critical-care injectable antibiotic widely used in ICUs, emergency wards, and multispecialty hospitals. It is a strong hospital and anti-infective segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent hospital demand and institutional procurement, as meropenem is a key reserve antibiotic used in serious infections. Hospitals maintain continuous stock, ensuring regular bulk orders and stable business flow.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in critical-care injectable and antibiotic segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and institutional suppliers benefit from high-value hospital orders, ICU-based demand, and continuous infection management protocols, making it a stable and high-turnover pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in hospital antibiotic injectables can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the critical-care segment.